International Stem Cell CORP
ISCO· OTC
Released Aug 15, 2011, after the close
10-Q filed Aug 15, 2011, 46 days after period end · 0001193125-11-223254
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $1.11M | $441.12K |
| Net Income | -$2.39M | $4.23M |
| EPS Diluted | -$0.03 | $0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 15, 2011 · 46 d after period end